National Cancer Institute: Cancer Statistics Review 1973–1989.Bethesda, MD, United States Department of Health and Human Services, 1992.
2.
HarrisN.L., JaffeE.S., SteinH.A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood1994; 84: 1361–1392.
3.
CallT.G., PhylikyR.L., NoelP.Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with leukemia in emphasis on changes in initial stage at diagnosis. Mayo Clin Proc.1994; 69: 323–328.
4.
PangalisG.A., NathwaniB.N., RappaportH.Malignant lymphoma, well differentiated lymphocytic: its relationship with chronic lymphocytic leukemia and macroglobulinemia of Waldenström. Cancer.1977; 39: 999–1010.
5.
PughW.C., ManningJ.T., ButlerJ.J.Paraimmunoblastic variant of small lymphocytic lymphoma/leukemia. Am J Surg Pathol.1988; 12: 907–917.
6.
JuliussonG., OscierD.G., FitchettM.Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med.1990; 323: 720–724.
7.
YounesA., PughW.C., GoodacreA.Polysomy of chromosome 12 in 60 patients with non-Hodgkin's lymphoma assessed by fluorescence in situ hybridization: differences between follicular and diffuse large cell lymphoma. Genes Chromosom Cancer.1994; 9(3) 161–167.
8.
MedeirosL.J., StricklerJ.G., PickerLJ. “Well-differentiated” lymphocytic neoplasms: Immunologic findings correlated with clinical presentation and morphological features. Am J Pathol.1987; 129: 523–535.
9.
BurnsB.F., WarnkeR.A., DoggettR.S.Expression of a T-cell antigen (Leu-1) by B-cell lymphomas. Am J Pathol.1983; 113: 165–171.
10.
SundeenJ.T., LonqoD.L., JaffeeE.S.CD5 expression in B-cell small lymphocytic malignancies: correlations with clinical presentation and sites of disease. Am J Surg Pathol.1992; 6: 130–137, 1992.
11.
DorfmanD.M., PinkusG.S.Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol.1994; 7: 326–331.
12.
AlmasriN.M., DuqueR.E., IturraspeJ.Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol.1992; 40: 259–263.
13.
KeatingM.J., KantarjianH., O'BrienS.Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. J Clin Oncol.1991: 9; 44–49.
14.
JuliussonG., Elmborn-RosenborgA., LiliemarkJ.Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine. N Engl J Med.1992; 327: 1056–1061.
FaconT., BrouillardM., DuhamelA.Prognostic factors in Waldenstrom's macroglobulinemia: a report of 167 cases. J Clin Oncol.1993; 11: 1553–1558.
17.
HarrisN.L., BhanA.K.B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation. Hum Pathol.1985; 16: 829–837.
NganB.Y., WarnkeR.A., WilsonM.Monocytoid B-cell lymphoma: a study of 36 cases. Hum Pathol.1991; 22: 409–421.
20.
NizzeH., CogliattiS.B., von SchillingC.Monocytoid B-cell lymphoma: Morphological variants and relationship to low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue. Histopathology.1991; 18: 403–414.
21.
FisherR.I., DahlbergS., NathwaniB.N.A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories). A Southwest Oncology Group study. Blood.1995; 85: 1075–1082.
22.
WotherspoonA.C., DoglioniC., DissT.C.Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.Lancet.1993; 342: 575–577.
23.
RoggeroE., ZuccaE., PinottiG.Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa associated lymphoid tissue. Ann Intern Med.1995; 122: 767–769.
24.
BayerdorfferE., NeubauerA., RudolphB.Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection MALT Lymphoma Study Group. Lancet.1995; 345: 1591–1594.
25.
WotherspoonA.C., FinnT.M., IsaacsonP.G.Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood.1995; 85: 2000–2004.
26.
PanL., DissT., CunninghamD.The bcl-2 gene in primary B-cell lymphoma of mucosa associated lymphoid tissue (MALT). Am J Pathol.1989; 135: 7–11.
27.
MeloJ.V., HedgeU., Parreira. Splenic lymphoma with circulating villous lymphocytes: Differential diagnosis of B cell leukaemias with large spleens. J Clin Pathol.1987; 40: 642–651.
28.
MulliganS.P., MatutesE., DeardenC.Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. Br J Haematol.1991; 78: 206–209.
29.
MedeirosL.J., van KriekenJ., JaffeE.S.Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiationBlood.1990; 76: 2086–2090.
30.
BanksP.M., ChanJ., ClearyM.L.Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol.1992; 16: 637–640.
31.
BookmanM.A., LardelliP., JaffeE.S.Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic and prognostic factors. J Natl Cancer Inst.1009; 82: 742–748.
32.
ZuccaE., SteinH., CoiffierB.European Lymphoma Task Force: (ELTF): report of the workshop on Mantle Cell Lymphoma (MCL). Ann Oncol.1994; 5: 507–511.
33.
RosenbergC.L., WongE., PettyE.M.PRAD1, a candidate bcl-1 oncogene: mapping and expression breakpoint region in centrocytic lymphomas. Proc Natl Acad Sci U S A.1991; 88: 9638–9642.
34.
AlkanS., SchnitzerB., ThompsonJ.L.Cyclin D1 protein expression in mantle cell lymphoma. Ann Oncol.1995; 6: 567.
35.
SegalG.H., MasihA.S., FoxA.C.CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood.1995; 85: 1570–1579.
36.
MannR.B., BerardC.W.Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol.1983; 1: 187–192.
37.
MartinA.R., WeisenburgerD.D., ChanW.C.Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood.1995; 85: 3671–3678.
38.
TsujimotoT., CossmanJ., JaffeE.Involvement of the bcl-2 gene in human follicular lymphoma. Science.1985; 288: 1440.
39.
UtzG.L., SwerdlowS.H.Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: comparison of MT2 and bcl-2 antibodies. Hum Pathol.1993; 24: 1155–1158.
40.
GribbenJ.G., FreedmanA.S., NeubergD.Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med.1991; 325: 1525–1533.
41.
LimpensJ., de JongD., van KriekenJ.H.bcl-2 rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene.1991; 6: 2271–2276.
